Clinical Trials Logo

Sensorineural Hearing Loss clinical trials

View clinical trials related to Sensorineural Hearing Loss.

Filter by:

NCT ID: NCT05488535 Completed - Hearing Loss Clinical Trials

Non-significant Risk Study of a Cochlear Implant Headpiece

Start date: February 28, 2019
Phase:
Study type: Interventional

This study aims to evaluate a cochlear implant headpiece.

NCT ID: NCT05451628 Recruiting - Clinical trials for Sensorineural Hearing Loss

Anatomy-Based Fitting in Unexperienced Cochlear Implant Users

ABFmulti
Start date: March 30, 2022
Phase: N/A
Study type: Interventional

Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.

NCT ID: NCT05402969 Recruiting - Fibrosis Clinical Trials

Evaluation of Electrode-modiolus Distance and Cochlear Fibrosis Using Depth Sounding and Spectroscopy Tools

TIMAGING
Start date: January 12, 2023
Phase:
Study type: Observational

Cochlear fibrosis development can compromise the success and the outcomes of the cochlear implantation (CI) thus affecting the quality of life of the implanted patient. Correlating the results of the Transimpedance Matrix (TIM) measurements to the implant electrode location determined by the Cone Beam Computer Tomography (CBCT), this study aims to identify a range of TIM profiles within the implanted population, certain profiles suggesting the growth of the fibrosis tissue in cochlea

NCT ID: NCT05107466 Recruiting - Hearing Loss Clinical Trials

Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss

Start date: July 28, 2023
Phase:
Study type: Observational

This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing loss. This test measures the participant's brain's response (so called "brain waves") to specific visual images. This study will help the investigators determine whether this test could be used to improve treatments for patients with hearing loss. The "Visual Evoked Potential" measurement test is already used in the investigator's Neurology clinic at Dartmouth Hitchcock Medical Center for various conditions to measure "early" brain responses that occur in the first 1-2 seconds after a new cue. Our research aims to explore your brain's response just after that early 1-2 second period by looking at a specific response called the "P300". The P300 wave is a brain response to new or different images or sounds. A visual evoked P300 has not been studied in individuals with hearing loss. The investigators will compare the results of this test to standard auditory tests, tests of cognitive function, and cochlear implant patient outcomes to explore how these factors can predict successful use of a hearing aid or cochlear implant.

NCT ID: NCT05061758 Withdrawn - Clinical trials for Sensorineural Hearing Loss

A Trial of LY3056480 in Patients With SNLH

VESTA
Start date: September 2022
Phase: Phase 2
Study type: Interventional

A phase 2 trial with LY3056480 in patients with stable SNHL

NCT ID: NCT04934605 Active, not recruiting - Clinical trials for Sensorineural Hearing Loss

Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA

Start date: May 1, 2010
Phase:
Study type: Observational

To explore the genotype-phenotype correlation of SLC26A4 mutations in cochlear-implanted patients with enlarged vestibular aqueduct.

NCT ID: NCT04750642 Active, not recruiting - Clinical trials for Sensorineural Hearing Loss

Cochlear Implant With Dexamethasone Eluting Electrode Array

Start date: October 4, 2021
Phase: N/A
Study type: Interventional

An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

NCT ID: NCT04741048 Withdrawn - Clinical trials for Sensorineural Hearing Loss

Hearing Implant Performance in Adults With Low-Frequency Residual Hearing

Start date: March 8, 2021
Phase: N/A
Study type: Interventional

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI624 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

NCT ID: NCT04741009 Recruiting - Clinical trials for Sensorineural Hearing Loss

Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

Start date: December 16, 2021
Phase: N/A
Study type: Interventional

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

NCT ID: NCT04733950 Recruiting - Clinical trials for Sensorineural Hearing Loss

Cochlear Implanted Listening Effort and Hearing Attention

EffICAtt
Start date: December 8, 2021
Phase: N/A
Study type: Interventional

Cochlear implant users perceive mainly sound amplitude modulation cues. Processing of these amplitude modulations can be subject to interferences, so that the perception of a modulation in a target sound can be impaired by a superimposed sound if this sound contains a similar modulation. Such phenomenon, which is observed both in subjects with normal-hearing and in cochlear-implant users, could be explained by difficulties to direct attention to relevant information in complex sound signals. Selective auditory attention also plays a crucial role in speech comprehension in cocktail-party situations where the speech of multiple talkers get mixed at the ear of a listener. Cochlear implant users typically struggle in these cocktail-party situations and report intense listening effort. The present clinical trial aims at evaluating the contribution of selective auditory attention for sound modulations to the listening effort of patients with cochlear implants and of healthy volunteers with normal-hearing during speech perception under cocktail-party-like conditions. Selective auditory attention abilities of patients and controls will be assessed using a psychoacoustical test whereby their ability to detect a target sound amplitude modulation will be measured both in the absence and in the presence of an interfering (i.e. distracting) amplitude modulation occurring in a distant spectral region from that of the target. The effect of this distractor's presence on modulation detection performance will serve as a behavioural index of the subject's auditory attention capacities. The attentional capacity index will then be tested as a predicting factor for the listening effort of the subject during a speech-in-noise consonant identification task. Listening effort will be measured from the pupil dilation response to the presented speech units (pseudowords). This study will enhance our understanding of cochlear implant user's perception and listening effort and will serve as a basis for prognostic tests of listening effort and of implantation success for cochlear implant candidates, based on a simple measurement of auditory attentional abilities.